The impact of HLA class I and EBV latency‐II antigen‐specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma

In 40% of cases of classical Hodgkin lymphoma (cHL), Epstein–Barr virus (EBV) latency‐II antigens [EBV nuclear antigen 1 (EBNA1)/latent membrane protein (LMP)1/LMP2A] are present (EBV(+)cHL) in the malignant cells and antigen presentation is intact. Previous studies have shown consistently that HLA‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, K., Wockner, L., Brennan, R. M., Keane, C., Chattopadhyay, P. K., Roederer, M., Price, D. A., Cole, D. K., Hassan, B., Beck, K., Gottlieb, D., Ritchie, D. S., Seymour, J. F., Vari, F., Crooks, P., Burrows, S. R., Gandhi, M. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711160/
https://www.ncbi.nlm.nih.gov/pubmed/26422112
http://dx.doi.org/10.1111/cei.12716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711160/
https://www.ncbi.nlm.nih.gov/pubmed/26422112
http://dx.doi.org/10.1111/cei.12716

Ejemplares similares